Medicxi Ventures Management (Jersey) Ltd
An institutional investment manager in ST. HELIER. Its Form 13F for the quarter ended Jun 30, 2026, filed Aug 4, 2026. SEC CIK 1715579.
- Reported value$177.4m
- Positions3
Holdings: 3 positions
The filing on sec.govAs filed, largest first. Reported value is what the manager stated for each position at the quarter end, in US dollars; it is filing data, not a price. Weight is the position's share of the total reported value. Changes compare with the 13F for the quarter ended 2026-03-31.
| Issuer | Class | CUSIP | Reported value$m | Weight | Shares | Put or call | Change on the quarter before |
|---|---|---|---|---|---|---|---|
| Phathom Pharmaceuticals IncPHAT | COM | 71722W107 | 81.0 | 45.6% | 7,464,572 | Unchanged | |
| Newamsterdam Pharma Company | ORDINARY SHARES | N62509109 | 74.9 | 42.2% | 2,208,639 | Reduced−465,543 | |
| Aura Biosciences IncAURA | COM | 05153U107 | 21.6 | 12.2% | 3,039,892 | Unchanged |
Sold out: 1 position
Held at the end of the quarter before and not reported this quarter.
| Issuer | Class | CUSIP | Reported value$ | Weight | Shares | Put or call | Change on the quarter before |
|---|---|---|---|---|---|---|---|
| Centessa Pharmaceuticals plc | SPONSORED ADS | 152309100 | 0.0 | 0.0% | 0 | Sold out−19,963,157 |
Source: SEC EDGAR, Form 13F-HR, accession 0001193125-26-332000 (on sec.gov). Last ingested by Listed: Oct 22, 2026, 05:26 ET. Listed shows no prices and gives no investment advice.